Inventor
Toyomasa Katagiri
Inventor
Tokyo, JP
Overview
Patents· 21 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07KPeptides19%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms19%
A61KPreparations for medical, dental or toiletry purposes15%
G01NInvestigating or analysing materials by determining their chemical or physical properties15%
C12NMicroorganisms or enzymes6%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
10,669,310Peptide for cancer treatment and pharmaceutical composition containing same20209,725,490'ERAP1-derived peptide and use thereof'20179,540,447'Method for treating synovial sarcoma'20179,187,557'Genes and polypeptides relating to breast cancers'20159,139,655'Tumor-targeting monoclonal antibodies to FZD10 and uses thereof'20158,975,086'Method for treating or preventing bladder cancer using the DEPDC1 polypeptide'20158,846,038'Method for treating synovial sarcoma'20148,795,976'Gene and polypeptide relating to breast cancer'20148,697,068'Method for treating synovial sarcoma'20148,685,641'Method of screening compounds for treating bladder cancer'20148,673,548'Genes and polypeptides relating to breast cancers'20148,221,751'Tumor-targeting monoclonal antibodies to FZD10 and uses thereof'20128,044,193'Short interfering RNAs targeted to T-LAK cell-originated protein kinase (TOPK) polynucleotide'20118,029,981'Hypoxia-inducible protein 2 (HIG2), a diagnostic marker for clear cell renal cell carcinoma'20117,998,695'Method of diagnosing bladder cancer'20117,943,730'Genes and polypeptides relating to human pancreatic cancers'20117,803,370'Method for treating synovial sarcoma'20107,727,714'Hypoxia-inducible protein 2 (HIG2), a diagnostic marker for clear cell renal cell carcinoma'20107,601,826'Genes and polypeptides relating to human pancreatic cancers'20097,531,300'Method of diagnosing breast cancer'20097,521,205'Genes and polypeptides relating to prostate cancers'2009Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2009–2020Patents assigned to ONCOTHERAPY SCIENCE INC (21)· patent assignee history
2009–2011Based in Shinagawa-ku, JP· patent location history
2010–2015Based in Tokyo, JP· patent location history
2011–2014Based in Bunkyo-ku, JP· patent location history
2012–2017Patents assigned to KATAGIRI TOYOMASA (8)· patent assignee history
2012–2015Patents assigned to NAKAMURA YUSUKE (7)· patent assignee history
2012–2015Patents assigned to NAKATSURU SHUICHI (5)· patent assignee history
2012–2015Patents assigned to ENDO KEIGO (2)· patent assignee history
2012–2020Based in Tokushima, JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ONCOTHERAPY SCIENCE INC | 21 | 2009–2020 |
| KATAGIRI TOYOMASAself | 8 | 2012–2017 |
| NAKAMURA YUSUKE | 7 | 2012–2015 |
| NAKATSURU SHUICHI | 5 | 2012–2015 |
| ENDO KEIGO | 2 | 2012–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Tokyo, JP | 7 | 2010–2015 |
| Tokushima, JP | 6 | 2012–2020 |
| Shinagawa-ku, JP | 5 | 2009–2011 |
| Bunkyo-ku, JP | 3 | 2011–2014 |